Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice

home / webinars-webcasts / use-of-parp-inhibitors-in-breast-cancer-implications-for-pharmacy-practice

About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.

© 2024 MJH Life Sciences

All rights reserved.